A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (X-TOLE4)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502282-24-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children and adolescents with Autism Spectrum Disorders.
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-503678-18-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502505-15-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures (X-ACKT)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502286-16-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson’s Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-501783-18-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502000-73-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis
https://clinicaltrials.gov/study/NCT07008378?cond=Multiple+Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Effect of Bobath Therapy on Balance Alterations in Patients With Multiple Sclerosis
https://clinicaltrials.gov/study/NCT07006259?cond=Multiple+Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis
https://clinicaltrials.gov/study/NCT07006805?cond=Multiple+Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Clinical trial of ocrelizumab in patients with relapsing and primary progressive multiple sclerosis
https://www.chictr.org.cn/showproj.html?proj=273442
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
ReHabGame: a game-based rehabilitation system for motor-impaired individuals
https://www.isrctn.com/ISRCTN10134617
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Changing physical activity and sedentary behaviour in people with MS to reduce fatigue: the iStep-MS study
https://www.isrctn.com/ISRCTN16944301
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Evaluating the short and long-term changes experienced by people with physical impairments who undertake supervised sports training
https://anzctr.org.au/ACTRN12625000343404.aspx
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Gut Microbiota Study of Multiple Sclerosis Patients and Their Matched Healthy Household Controls
https://www.chictr.org.cn/showproj.html?proj=268356
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Pilot randomized controlled trial of an online Nutrition information and behavior change program for people with Multiple Sclerosis (NutriMS-Plus)
http://drks.de/search/en/trial/DRKS00034413
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Gait adaptability on a virtual reality-based treadmill during neurorehabilitation: Study on the reliability and sensitivity to change of the C-Gait test
http://drks.de/search/en/trial/DRKS00033711
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Assessment of B cell reactivity against MLC1, GlialCAM and EBNA1 in patients with Multiple Sclerosis
http://drks.de/search/en/trial/DRKS00035749
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Using light glasses in patients suffering from Multiple Sclerosis-related fatigue
http://drks.de/search/en/trial/DRKS00036464
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Treadmill training under transcutaneous spinal cord stimulation - a randomized controlled trial in patients with spastic gait disorder in neurological rehabilitation
http://drks.de/search/en/trial/DRKS00036450
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Effects of High-Dose Methylprednisolone Therapy on Vaginal Microecology in Women with Multiple Sclerosis
http://drks.de/search/en/trial/DRKS00036329
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
